| Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses. | breast, |
| The interplay between c-Myc oncogene expression and circulating vascular endothelial growth factor (sVEGF), its antagonist receptor, soluble Flt-1 in diffuse large B cell lymphoma (DLBCL): relationship to patient outcome. | lymphoma, |
| Expression of c-myc oncoprotein in laryngeal squamous cell carcinoma. | laryngeal, |
| Hemopoietic neoplasms in lethally irradiated mice repopulated with bone marrow cells carrying the human c-myc oncogene: a repopulation assay. | neoplasm, |
| Deregulated expression of the Myc cellular oncogene drives development of mouse Burkitt-like lymphomas from naive B cells. | lymphoma, |
| Induction of apoptosis by flavopiridol in human neuroblastoma cells is enhanced under hypoxia and associated with N-myc proto-oncogene down-regulation. | neuroblastoma, |
| Overexpression of wild-type MET leads to the development of nonprogressive neoplasms. The lesions progressed to mammary adenocarcinoma when a second protooncogene, MYC, was overexpressed, indicating that MET and MYC cooperate in mammary tumorigenesis. | neoplasm, |
| Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. | breast, |
| Immunohistochemical localization of c-myc oncogene product in oral papilloma. | oral |
| Posttranscriptional regulation of c-myc proto-oncogene expression and growth inhibition by recombinant human interferon-beta ser17 in a human colon carcinoma cell line. | colorectal, |
| DNA-activated protein kinase in Raji Burkitt s lymphoma cells. Phosphorylation of c-Myc oncoprotein. | lymphoma, |
| Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue. | cervical, |
| Amplification of the N-myc oncogene in an adenocarcinoma cell line of the lung. | lung, |
| c-myc oncogene copy number in squamous carcinoma of the head and neck. | HNSC, |
| Human papillomavirus type-related DNA and c-myc oncogene alterations in colon cancer cell lines. | colorectal, |
| c-fos and c-myc oncoprotein expression in human hepatocellular carcinomas. | liver, |
| The MYC oncogene in breast cancer progression: from benign epithelium to invasive carcinoma. | breast, |
| Evaluation of c-myc proto-oncogene in primary human breast carcinomas. | breast, |
| Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas. | breast, |
| N-myc oncogene amplification in a pediatric case of glioblastoma multiforme. | glioblastoma,pediatric, |